How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that may help provide context for individual metabolic predispositions and peptide receptor function
Data on CJC-1295 in specific patient populations (elderly, metabolically compromised, post-surgical) is limited
In the U.S., tesamorelin is sold under the brand name Egrifta and is used to treat HIV-positive patients with lipodystrophy caused by long-term antiretroviral therapy (ART)
San Antonio residents and business owners need all the energy they can get in todays fast-paced world
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
Vitamin B12 boost energy, metabolism and immune function with a simple B12 injection
